About
Mission

Manufacturing gene therapies for life.

Our mission is to enable access to life changing gene therapies and help bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech and pharma companies and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them the most.

About
Approach

Forge is building capacity to directly address the growing demand for gene therapy manufacturing.
Forge is currently building the "Hearth”, a 200,000+ ft2 custom-designed cGMP facility, dedicated to AAV viral vector manufacturing. We offer end-to-end manufacturing services to accelerate gene therapy programs from preclinical stage through clinical, and on to commercial manufacturing.
With the Hearth as our foundation, Forge is building a promising pipeline of disease-modifying AAV-based therapies to potentially help patients with rare genetic diseases. Forge is a true gene therapy development engine bringing together access to quality, in-house manufacturing, the experience of our team in gene therapy product development, and an exciting pipeline of new therapies for patients.
About
Leadership


Timothy J. Miller, Ph.D.
CEO, President and Co-Founder


Timothy J. Miller, Ph.D.
CEO, President and Co-Founder


David Dismuke, Ph.D.
Chief Technical Officer


Erandi De Silva, Ph.D.
Co-Founder & Senior Vice President of Product Development


Jaysson Eicholtz
Co-Founder & Chief Operating Officer


John Maslowski
Chief Commercial Officer


Maria Escolar, M.D.
Chief Medical Officer


Christopher Shilling
Senior Vice President of Regulatory Affairs and Quality


Magdalena Tyrpien
Senior Vice President and Head of Business Development


Steven Goden
Senior Vice President of Finance & Operations


Christina Perry
Senior Vice President of Finance & Investor Relations


Juan Ruiz, M.D., Ph.D.
Senior Vice President of Clinical Affairs


Frank Agbogbo, Ph.D.
Vice President of Process Development


Meghan Leonard
Vice President of Quality Management


Taleen Barsoumian
Vice President of Client Development

About
Board


Timothy J. Miller
Forge Biologics

Chris Garabedian
Xontogeny

Matthew Hammond
RA Capital

Fred Callori
Xontogeny

Molly Bonakdarpour
Drive Capital
About
Scientific & Manufacturing Advisory Board


Steven J. Gray, Ph.D.
UT Southwestern

Robert Kotin, Ph.D.
Stealth Newco

Karen Kozarsky, Ph.D.
SwanBio Therapeutics

Haiyan Ma, Ph.D.
Northern Biomolecular Services

Simon Waddington, Ph.D.
University College London